Annual D&A
$22.19 M
+$1.63 M+7.93%
31 December 2023
Summary:
Sangamo Therapeutics annual depreciation & amortization is currently $22.19 million, with the most recent change of +$1.63 million (+7.93%) on 31 December 2023. During the last 3 years, it has risen by +$8.82 million (+66.00%). SGMO annual D&A is now at all-time high.SGMO Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$2.13 M
-$446.00 K-17.33%
30 September 2024
Summary:
Sangamo Therapeutics quarterly depreciation & amortization is currently $2.13 million, with the most recent change of -$446.00 thousand (-17.33%) on 30 September 2024. Over the past year, it has dropped by -$5.29 million (-71.33%). SGMO quarterly D&A is now -71.33% below its all-time high of $7.42 million, reached on 30 September 2023.SGMO Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$10.23 M
-$5.29 M-34.09%
30 September 2024
Summary:
Sangamo Therapeutics TTM depreciation & amortization is currently $10.23 million, with the most recent change of -$5.29 million (-34.09%) on 30 September 2024. Over the past year, it has dropped by -$14.39 million (-58.43%). SGMO TTM D&A is now -58.43% below its all-time high of $24.62 million, reached on 30 September 2023.SGMO TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SGMO Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +7.9% | -71.3% | -58.4% |
| 3 y3 years | +66.0% | -53.7% | -37.8% |
| 5 y5 years | +840.7% | -29.9% | +41.6% |
SGMO Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +66.0% | -71.3% | at low | -58.4% | at low |
| 5 y | 5 years | at high | +840.7% | -71.3% | at low | -58.4% | +41.6% |
| alltime | all time | at high | +3335.0% | -71.3% | +269.5% | -58.4% | +776.5% |
Sangamo Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $2.13 M(-17.3%) | $10.23 M(-34.1%) |
| June 2024 | - | $2.57 M(+1.9%) | $15.53 M(-18.9%) |
| Mar 2024 | - | $2.53 M(-16.1%) | $19.14 M(-13.8%) |
| Dec 2023 | $22.19 M(+7.9%) | $3.01 M(-59.4%) | $22.19 M(-9.9%) |
| Sept 2023 | - | $7.42 M(+20.0%) | $24.62 M(+10.0%) |
| June 2023 | - | $6.18 M(+10.8%) | $22.38 M(+5.6%) |
| Mar 2023 | - | $5.58 M(+2.6%) | $21.20 M(+3.1%) |
| Dec 2022 | $20.56 M(+16.6%) | $5.44 M(+5.0%) | $20.56 M(+2.9%) |
| Sept 2022 | - | $5.18 M(+3.6%) | $19.98 M(+3.0%) |
| June 2022 | - | $5.00 M(+1.3%) | $19.39 M(+3.8%) |
| Mar 2022 | - | $4.94 M(+1.6%) | $18.68 M(+5.9%) |
| Dec 2021 | $17.64 M(+31.9%) | $4.86 M(+5.8%) | $17.64 M(+7.3%) |
| Sept 2021 | - | $4.59 M(+7.1%) | $16.44 M(+8.7%) |
| June 2021 | - | $4.29 M(+10.0%) | $15.13 M(+7.5%) |
| Mar 2021 | - | $3.90 M(+6.4%) | $14.07 M(+5.2%) |
| Dec 2020 | $13.37 M(+39.2%) | $3.66 M(+11.8%) | $13.37 M(+4.7%) |
| Sept 2020 | - | $3.28 M(+1.5%) | $12.77 M(+2.0%) |
| June 2020 | - | $3.23 M(+1.0%) | $12.53 M(+10.8%) |
| Mar 2020 | - | $3.20 M(+4.2%) | $11.31 M(+17.7%) |
| Dec 2019 | $9.61 M(+307.2%) | $3.07 M(+1.2%) | $9.61 M(+32.9%) |
| Sept 2019 | - | $3.03 M(+50.9%) | $7.23 M(+55.2%) |
| June 2019 | - | $2.01 M(+34.2%) | $4.66 M(+42.5%) |
| Mar 2019 | - | $1.50 M(+116.6%) | $3.27 M(+38.5%) |
| Dec 2018 | $2.36 M(+57.5%) | $691.00 K(+49.9%) | $2.36 M(+10.4%) |
| Sept 2018 | - | $461.00 K(-25.5%) | $2.14 M(+2.3%) |
| June 2018 | - | $619.00 K(+5.3%) | $2.09 M(+16.9%) |
| Mar 2018 | - | $588.00 K(+25.6%) | $1.78 M(+19.2%) |
| Dec 2017 | $1.50 M(+50.3%) | $468.00 K(+13.6%) | $1.50 M(+16.8%) |
| Sept 2017 | - | $412.00 K(+30.0%) | $1.28 M(+14.3%) |
| June 2017 | - | $317.00 K(+5.3%) | $1.12 M(+6.6%) |
| Mar 2017 | - | $301.00 K(+19.4%) | $1.05 M(+5.6%) |
| Dec 2016 | $997.00 K(+0.9%) | $252.00 K(0.0%) | $997.00 K(+0.9%) |
| Sept 2016 | - | $252.00 K(+1.6%) | $988.00 K(-6.2%) |
| June 2016 | - | $248.00 K(+1.2%) | $1.05 M(-3.0%) |
| Mar 2016 | - | $245.00 K(+0.8%) | $1.09 M(+9.9%) |
| Dec 2015 | $988.00 K(+80.0%) | $243.00 K(-23.3%) | $988.00 K(+10.5%) |
| Sept 2015 | - | $317.00 K(+12.8%) | $894.00 K(+23.0%) |
| June 2015 | - | $281.00 K(+91.2%) | $727.00 K(+26.9%) |
| Mar 2015 | - | $147.00 K(-1.3%) | $573.00 K(+4.4%) |
| Dec 2014 | $549.00 K(-3.5%) | $149.00 K(-0.7%) | $549.00 K(+4.8%) |
| Sept 2014 | - | $150.00 K(+18.1%) | $524.00 K(+1.9%) |
| June 2014 | - | $127.00 K(+3.3%) | $514.00 K(-5.7%) |
| Mar 2014 | - | $123.00 K(-0.8%) | $545.00 K(-4.2%) |
| Dec 2013 | $569.00 K(-13.8%) | $124.00 K(-11.4%) | $569.00 K(-6.0%) |
| Sept 2013 | - | $140.00 K(-11.4%) | $605.00 K(-4.1%) |
| June 2013 | - | $158.00 K(+7.5%) | $631.00 K(-1.3%) |
| Mar 2013 | - | $147.00 K(-8.1%) | $639.00 K(-3.2%) |
| Dec 2012 | $660.00 K | $160.00 K(-3.6%) | $660.00 K(-1.0%) |
| Sept 2012 | - | $166.00 K(0.0%) | $667.00 K(+0.9%) |
| June 2012 | - | $166.00 K(-1.2%) | $661.00 K(+1.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | $168.00 K(+0.6%) | $652.00 K(+0.9%) |
| Dec 2011 | $646.00 K(-4.4%) | $167.00 K(+4.4%) | $646.00 K(-1.2%) |
| Sept 2011 | - | $160.00 K(+1.9%) | $654.00 K(-1.5%) |
| June 2011 | - | $157.00 K(-3.1%) | $664.00 K(-1.9%) |
| Mar 2011 | - | $162.00 K(-7.4%) | $677.00 K(+0.1%) |
| Dec 2010 | $676.00 K(+18.2%) | $175.00 K(+2.9%) | $676.00 K(+6.6%) |
| Sept 2010 | - | $170.00 K(0.0%) | $634.00 K(+3.6%) |
| June 2010 | - | $170.00 K(+5.6%) | $612.00 K(+3.9%) |
| Mar 2010 | - | $161.00 K(+21.1%) | $589.00 K(+3.0%) |
| Dec 2009 | $572.00 K(+9.4%) | $133.00 K(-10.1%) | $572.00 K(-1.5%) |
| Sept 2009 | - | $148.00 K(+0.7%) | $581.00 K(+1.9%) |
| June 2009 | - | $147.00 K(+2.1%) | $570.00 K(+3.3%) |
| Mar 2009 | - | $144.00 K(+1.4%) | $552.00 K(+5.5%) |
| Dec 2008 | $523.00 K(+90.9%) | $142.00 K(+3.6%) | $523.00 K(+11.8%) |
| Sept 2008 | - | $137.00 K(+6.2%) | $468.00 K(-65.6%) |
| June 2008 | - | $129.00 K(+12.2%) | $1.36 M(+61.8%) |
| Mar 2008 | - | $115.00 K(+32.2%) | $841.00 K(+206.9%) |
| Dec 2007 | $274.00 K(-139.9%) | $87.00 K(-91.6%) | $274.00 K(-221.2%) |
| Sept 2007 | - | $1.03 M(-363.4%) | -$226.00 K(-85.1%) |
| June 2007 | - | -$391.00 K(-13.5%) | -$1.51 M(+30.2%) |
| Mar 2007 | - | -$452.00 K(+9.4%) | -$1.16 M(+69.4%) |
| Dec 2006 | -$686.00 K(-240.6%) | -$413.00 K(+60.7%) | -$686.00 K(+241.3%) |
| Sept 2006 | - | -$257.00 K(+542.5%) | -$201.00 K(-252.3%) |
| June 2006 | - | -$40.00 K(-266.7%) | $132.00 K(-58.8%) |
| Mar 2006 | - | $24.00 K(-66.7%) | $320.00 K(-34.4%) |
| Dec 2005 | $488.00 K(-67.0%) | $72.00 K(-5.3%) | $488.00 K(-20.4%) |
| Sept 2005 | - | $76.00 K(-48.6%) | $613.00 K(-29.1%) |
| June 2005 | - | $148.00 K(-22.9%) | $865.00 K(-26.5%) |
| Mar 2005 | - | $192.00 K(-2.5%) | $1.18 M(-20.5%) |
| Dec 2004 | $1.48 M(-31.8%) | $197.00 K(-39.9%) | $1.48 M(-8.4%) |
| Sept 2004 | - | $328.00 K(-28.7%) | $1.61 M(-39.8%) |
| June 2004 | - | $460.00 K(-7.1%) | $2.68 M(+22.4%) |
| Mar 2004 | - | $495.00 K(+49.1%) | $2.19 M(+1.0%) |
| Dec 2003 | $2.17 M(-34.4%) | $332.00 K(-76.2%) | $2.17 M(-47.3%) |
| Sept 2003 | - | $1.40 M(-4603.2%) | $4.12 M(+33.6%) |
| June 2003 | - | -$31.00 K(-106.6%) | $3.08 M(-10.8%) |
| Mar 2003 | - | $473.00 K(-79.2%) | $3.45 M(+4.4%) |
| Dec 2002 | $3.31 M(-23.2%) | $2.28 M(+533.1%) | $3.31 M(-29.8%) |
| Sept 2002 | - | $360.00 K(+5.3%) | $4.71 M(+52.1%) |
| June 2002 | - | $342.00 K(+4.3%) | $3.10 M(-15.6%) |
| Mar 2002 | - | $328.00 K(-91.1%) | $3.67 M(-14.8%) |
| Dec 2001 | $4.31 M(-17.6%) | $3.68 M(-393.5%) | $4.31 M(+80.6%) |
| Sept 2001 | - | -$1.25 M(-237.0%) | $2.39 M(-52.4%) |
| June 2001 | - | $916.00 K(-5.1%) | $5.01 M(-5.6%) |
| Mar 2001 | - | $965.00 K(-45.2%) | $5.31 M(+1.5%) |
| Dec 2000 | $5.23 M(+647.4%) | $1.76 M(+28.7%) | $5.23 M(+50.7%) |
| Sept 2000 | - | $1.37 M(+12.5%) | $3.47 M(+65.0%) |
| June 2000 | - | $1.22 M(+37.1%) | $2.10 M(+137.1%) |
| Mar 2000 | - | $887.00 K | $887.00 K |
| Dec 1999 | $700.00 K | - | - |
FAQ
- What is Sangamo Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Sangamo Therapeutics?
- What is Sangamo Therapeutics annual D&A year-on-year change?
- What is Sangamo Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Sangamo Therapeutics?
- What is Sangamo Therapeutics quarterly D&A year-on-year change?
- What is Sangamo Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Sangamo Therapeutics?
- What is Sangamo Therapeutics TTM D&A year-on-year change?
What is Sangamo Therapeutics annual depreciation & amortization?
The current annual D&A of SGMO is $22.19 M
What is the all time high annual D&A for Sangamo Therapeutics?
Sangamo Therapeutics all-time high annual depreciation & amortization is $22.19 M
What is Sangamo Therapeutics annual D&A year-on-year change?
Over the past year, SGMO annual depreciation & amortization has changed by +$1.63 M (+7.93%)
What is Sangamo Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of SGMO is $2.13 M
What is the all time high quarterly D&A for Sangamo Therapeutics?
Sangamo Therapeutics all-time high quarterly depreciation & amortization is $7.42 M
What is Sangamo Therapeutics quarterly D&A year-on-year change?
Over the past year, SGMO quarterly depreciation & amortization has changed by -$5.29 M (-71.33%)
What is Sangamo Therapeutics TTM depreciation & amortization?
The current TTM D&A of SGMO is $10.23 M
What is the all time high TTM D&A for Sangamo Therapeutics?
Sangamo Therapeutics all-time high TTM depreciation & amortization is $24.62 M
What is Sangamo Therapeutics TTM D&A year-on-year change?
Over the past year, SGMO TTM depreciation & amortization has changed by -$14.39 M (-58.43%)